Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review

  • ID: 4319030
  • SWOT Analysis
  • 62 pages
  • GlobalData
  • Biocon
1 of 5

FEATURED COMPANIES

  • Abeona Therapeutics Inc
  • Morepen Laboratories Ltd
  • Panacea Biotec Ltd
  • Piramal Enterprises Ltd
  • MORE
Bio con Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bio con Ltd (Bio con) is a biopharmaceutical company that focuses on the research and development of therapies for the treatment of chronic conditions like cancer, diabetes and autoimmune. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations; and complex biologics both novels and biosimilar's including monoclonal antibodies (MAbs), rh-Insulin and insulin analogs. It also provides research services including discovery, development and manufacturing services for both small and large molecules. Bio con provides research solutions to the biotechnology and pharmaceutical companies worldwide. It has an overseas manufacturing facility at BioXcell, a biotechnology park in Johor, Malaysia. Bio con is headquartered in Bangalore, Karnataka, India.

Bio con Ltd Key Recent Developments

Jul 26, 2018: Bio con Q1FY19 revenue Rs 1,193 Chr, Up 21%; EBITDA up 25% at Rs 307 Chr; net profit up 47% at Rs 120 Chr
Jul 04, 2018: Boons Sterile Drug Product facility Receives EU GMP Certification
Jun 23, 2018: Boons Sterile Drug Product facility Receives EIR from U.S. FDA
May 02, 2018: Bio con Regulatory Audit Update
Apr 26, 2018: Bio con Q4FY18 Revenue Rs 1,237 Chr, Up 27%; EBITDA Up 30% at Rs 300 Chr; Net Profit Up 2% at Rs 130 Cr[TOPC : Pharma - Bio con Ltd]

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abeona Therapeutics Inc
  • Morepen Laboratories Ltd
  • Panacea Biotec Ltd
  • Piramal Enterprises Ltd
  • MORE
Section 1 - About the Company
Biocon Ltd - Key Facts
Biocon Ltd - Key Employees
Biocon Ltd - Key Employee Biographies
Biocon Ltd - Major Products and Services
Biocon Ltd - History
Biocon Ltd - Company Statement
Biocon Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

Section 2 – Company Analysis
Company Overview
Biocon Ltd - Business Description
Business Segment: Biologics
Overview
Performance
Business Segment: Branded Formulations
Overview
Performance
Business Segment: Research Services
Overview
Performance
Business Segment: Small Molecules
Overview
Performance
Geographical Segment: India
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: United States of America
Performance
R&D Overview
Biocon Ltd - Corporate Strategy
Biocon Ltd - SWOT Analysis
SWOT Analysis - Overview
Biocon Ltd - Strengths
Biocon Ltd - Weaknesses
Biocon Ltd - Opportunities
Biocon Ltd - Threats
Biocon Ltd - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Biocon Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments
Jul 26, 2018: Biocon Q1FY19 revenue Rs 1,193 Cr, Up 21%; EBITDA up 25% at Rs 307 Cr; net profit up 47% at Rs 120 Cr
Jul 04, 2018: Biocon’s Sterile Drug Product facility Receives EU GMP Certification
Jun 23, 2018: Biocon’s Sterile Drug Product facility Receives EIR from U.S. FDA
May 02, 2018: Biocon Regulatory Audit Update
Apr 26, 2018: Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27%; EBITDA Up 30% at Rs 300 Cr; Net Profit Up 2% at Rs 130 Cr[TOPC : Pharma - Biocon Ltd]
Mar 13, 2018: Update On Company Statement On US-FDA Inspection At Biocon Malaysia
Dec 13, 2017: Biocon's Clarification post media reports on “Biocon on the FDA list for not paying facility fee”
Nov 20, 2017: Biocon's Drug product Facility Receives EIR with VAI status, Inspection Closed
Oct 26, 2017: Biocon Q2FY18 Revenues at Rs 1019 Crore; EBITDA at Rs 233 Crore; Net Profit at Rs 69 Crore
Oct 25, 2017: Biocon Ranked Among Top 10 Global Pharma & Biotech Employers

Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Biocon Ltd, Key Facts
Biocon Ltd, Key Employees
Biocon Ltd, Key Employee Biographies
Biocon Ltd, Major Products and Services
Biocon Ltd, History
Biocon Ltd, Subsidiaries
Biocon Ltd, Joint Venture
Biocon Ltd, Key Competitors
Biocon Ltd, Ratios based on current share price
Biocon Ltd, Annual Ratios
Biocon Ltd, Interim Ratios
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Biocon Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Biocon Ltd, Performance Chart (2014 - 2018)
Biocon Ltd, Ratio Charts
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Biocon Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Sun Pharmaceutical Industries Ltd
  • Serum Institute of India Ltd
  • Piramal Enterprises Ltd
  • Panacea Biotec Ltd
  • Morepen Laboratories Ltd
  • Dr. Reddy's Laboratories Ltd
  • Bharat Immunologicals and Biologicals Corp Ltd
  • Abeona Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll